The National Institutes of Health has awarded the University of California, Los Angeles a $7.2 million life science grant to study genetic diseases and develop ways to diagnose rare genetic disorders. UCLA is the only university on the West Coast and one of only three in the United States with a laboratory that can carry out genomic sequence directly usable for patient care, making it the ideal university to receive this life science grant.
Science Market Update
Remember life as a starving student? How about grad school? How about your post doctoral fellowship?
Tags: 2014, University of Michigan Ann Arbor, BioResearch Product Faire Event, Life Science Event, Biotechnology Vendor Showcase, UC Riverside, UC San Francisco, UC Davis - Medical Center, UC Berkeley, UC Irvine, post doc, salary, UC Los Angeles
Are you struggling to find answers to your research challenges? Tired of using outdated technologies, techniques, and equipment? We may able to help. Biotechnology Calendar, Inc. would like to invite you to the 33rd semiannual Biotechnology Vendor Showcase™ Event on Thursday, April 3, 2014.
UCLA Market Highlights
With annual research expenditures of over $1 billion and one of the largest medical centers in the nation, Los Angeles provides one of the most active, research marketplace opportunities in the nation.
17 Fast Facts about UCLA Marketplace:
Are you a lab supplier who is looking to increase your presence or expand your influence at the top California Universities? Take advantage of these upcoming life science trade shows that will provide you with an effective way to network with leading California researchers:
Tags: 2014, CA, 2013, University of Southern California, Southwest, USC, Los Angeles, LAVS, San Diego, SDVS, BioResearch Product Faire Event, UC San Diego, Biotechnology Vendor Showcase, Riverside, UC Riverside, Irvine, UCI, UC Irvine, UCR, UC Los Angeles
The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.
Tags: 2014, CA, 2013, Southwest, Los Angeles, Autism, LAVS, UCDMC, BioResearch Product Faire Event, Funding, UCLA, Genetics, Research, Sacramento, Davis, NIH funding, UC Los Angeles, UC Davis, Biotechnology Vendor Showcase Event
The California Institute for Regenerative Medicine (CIRM) is a major funding agency for stem cell research in the Golden State. Since voters approved the establishment of the agency in 2004, the CIRM has spent billions on research and facilities with the aim of making California the stem cell capital of the US. Now, in a move to advance that research mission even further, the agency has announced awards of $32M to investigators and stem cell companies to create a biobank of diseased cell lines for the use of researchers around the world. Called the Human Induced Pluripotent Stem Cell (hiPSC) Initiative Awards, the project will generate and ensure the availability of high quality disease-specific hiPSC resources for disease modeling, target discovery and drug discovery and development for prevalent, genetically complex diseases.
Tags: 2014, CA, 2013, Stem cell research, Southwest, California, Los Angeles, Biobank, biobanking, LAVS, San Diego, SDVS, San Francisco, SFVS, UC San Diego, Biotechnology Vendor Showcase, UC San Francisco, CIRM, Parnassus Campus, tradeshow, Mission Bay Campus, Parnassus, Mission Bay, BVS, UC Los Angeles
Dr. Gary Michelson is a retired Los Angeles surgeon who made a lot of money ($1.35B) from a spinal surgical invention in 2005. Since then he's devoted himself and his considerable resources to philanthropy. One of his most passionate causes is reducing the rate of euthanasia for unwanted pets by promoting spaying and neutering, along with shelter adoption, training, and good vet care through the Los Angeles group Found Animals. Not content with the usual invasive practice of sterilizing pets, he also created the Michelson Prize and Grants to challenge research scientists to come up with a cheap, safe, and effective one-dose pill for cats and dogs to induce permanent infertility. The winner of the Michelson Prize in Reproductive Biology will take home $25M and the satisfaction of knowing that fewer pets will be put down because of overpopulation.
Tags: 2014, CA, 2013, University of Arizona, Northeast, University of Pennsylvania, UPenn, University of Southern California, vet care, veterinary research challenge, Northwest, crowdsourcing, Southwest, USC, Los Angeles, National Jewish Health, animal science, AZ, LAVS, Philadelphia, UAZ, BioResearch Product Faire Event, Denver, Front Line event, PA, CO, Biotechnology Vendor Showcase, Tucson, Irvine, UCI, UC Irvine, Dr. Gary Michelso, pets, spaying and neutering, NJH, UC Los Angeles